Sciclone Pharmaceuticals (SCLN) 10-K 2014 FY Annual report

EXHIBIT 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-52471, 333-62309, 333-77543, 333-81481, 333-84487, 333-85673, 333-30938, 333-72798, 333-72800, 333-107538, 333-38773, 333-159364, 333-176209 and 333-180131) and Form S-8  (Nos. 333-145281, 333-128482, 333-120008, 33-109256, 333-66832, 333-98081, 333-45820, 333-62059, 333-12169, 333-168668 and 333-183171) of SciClone Pharmaceuticals, Inc. of our reportdated March 12, 2015 relating to the financial statements, financial statement scheduleand the effectiveness of internal control over financial reporting, which appears in this Form 10‑K.

/s/ PricewaterhouseCoopers Zhong Tian, LLP

Shanghai, the People’s Republic of China

March 12, 2015